Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development
- 1 August 2006
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 15 (4) , 362-366
- https://doi.org/10.1097/00008469-200608000-00010
Abstract
Genetic predisposition has been suggested as a cofactor for cancer aetiology and a polymorphism in TP53 codon 72 has been associated as a susceptibility factor for several cancers. Nasopharyngeal carcinoma is a rare neoplasia in western civilizations and genetic predisposition might play an important role in its development. We evaluated the linkage of the polymorphic variants (Arg/Pro) on TP53 codon 72 with nasopharyngeal cancer development in a case–control study with 392 individuals from a northern Portuguese population, including 107 patients with nasopharyngeal carcinoma and 285 healthy controls. This study revealed a three-fold risk for carriers of Pro/Pro genotype either against carriers of Arg/Arg (OR=2.62; 95% CI=1.10–6.30; P=0.016) or total Arg carriers (OR=2.67; 95% CI=1.21–5.90; P=0.012). Moreover, step-wise logistic regression analysis identified Pro/Pro genotype (OR=3.1; 95% CI=1.3–7.3; P=0.009), age >49 at diagnosis (OR=2.5; 95% CI=1.6–4.0; PPKeywords
This publication has 42 references indexed in Scilit:
- Requirement of e6ap and the features of human papillomavirus e6 necessary to support degradation of p53Virology, 2003
- Absence of p53 Alterations in Nasopharyngeal Carcinoma Spanish Patients with Epstein–Barr Virus InfectionVirus Genes, 2003
- A slow acetylator genotype associated with an increased risk of advanced cervical cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumorUrological Research, 2000
- p53 polymorphism and risk of cervical cancerNature, 1998
- Interferon-alpha and p53 alleles involved in nasopharyngeal carcinomaCarcinogenesis: Integrative Cancer Research, 1997
- Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activityJournal of Virology, 1996
- p53 Polymorphisms and Haplotypes in Nasopharyngeal CancerHuman Heredity, 1996
- P53 polymorphisms and haplotypes in lung cancerCarcinogenesis: Integrative Cancer Research, 1995
- Codon 72 polymorphism of the TP53 geneNucleic Acids Research, 1990